Kindly MD (NAKA) Form 3: Andrew Creighton reports 892,857 shares

Kindly MD, Inc. (NAKA) reporting person Andrew Creighton disclosed direct beneficial ownership of 892,857 shares of common stock on a Form 3 filed for the 08/14/2025 event.

Rhea-AI Filing Summary

Kindly MD, Inc. (NAKA) reporting person Andrew Creighton disclosed direct beneficial ownership of 892,857 shares of common stock on a Form 3 filed for the 08/14/2025 event. The filing identifies Mr. Creighton as a director and as Chief Compliance Officer and is signed 08/19/2025. The Form 3 documents initial ownership and includes Exhibit 24 (Power of Attorney).

Positive

• Disclosure of direct beneficial ownership of 892,857 common shares
• Reporting person identified as Director and Chief Compliance Officer, improving transparency
• Form signed and dated (08/19/2025) and references Exhibit 24 (Power of Attorney)

Negative

• None.

Insights

Financial Analyst

TL;DR: Initial insider disclosure shows a substantial direct stake of 892,857 shares by a director/officer, a neutral routine compliance filing.

The Form 3 reports an initial ownership position by Andrew Creighton of 892,857 common shares, filed under Section 16. This is a standard Section 16 filing that increases transparency about insider holdings. There is no transaction, option grant, or derivative disclosed here—only direct common stock ownership. For investors, the filing confirms insider alignment with the company but contains no operational or financial metrics to reassess valuation.

Corporate Governance Expert

TL;DR: A routine initial beneficial ownership filing by an officer/director; governance disclosure appears complete with POA exhibit referenced.

The report identifies Mr. Creighton as both a director and the Chief Compliance Officer and attaches Exhibit 24 (Power of Attorney), suggesting proper execution and representation. The filing is signed and dated, meeting Section 16(a) reporting requirements. No amendments or joint filers are indicated. The disclosure supports compliance standards but does not signal governance changes or transactions.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Creighton Andrew John

Role Chief Compliance Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 892,857 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 3 for Kindly MD (NAKA) disclose?

The Form 3 discloses that Andrew Creighton beneficially owns 892,857 shares of Kindly MD common stock.

What is Andrew Creighton's role at Kindly MD (NAKA)?

The filing lists him as a Director and as Chief Compliance Officer.

When was the event requiring the Form 3 reported?

The event date reported on the form is 08/14/2025, with the Form signed on 08/19/2025.

Does the Form 3 report any derivative securities or transactions?

No. The filing shows only non-derivative common stock ownership; no options, warrants, or other derivatives are disclosed.

Is there any joint filing or amendment noted on the Form 3?

No. The form indicates it was filed by one reporting person and does not list an amendment date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/19/2025 - 04:54 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Creighton Andrew John

(Last) (First) (Middle)

5097 S 900 E SUITE 100

(Street)

SALT LAKE CITY UT 84117

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/14/2025

3. Issuer Name and Ticker or Trading Symbol
Kindly MD, Inc. [ NAKA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Compliance Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	892,857	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Andrew Creighton	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.